Barbara Shreve Briggs
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Barbara Shreve Briggs.
Tetrahedron Letters | 1991
Milton J. Zmijewski; Barbara Shreve Briggs; Allen R. Thompson; Ian G. Wright
Penicillin G amidase from E. coli has been shown to selectively acylate, in an efficient manner, the (2R,3S) isomer of a cis, racemic azetidinone intermediate used in a synthesis of loracarbef, a carbacephalosporin antibiotic. The acylation occurs using methyl phenylacetate (MPA) and using methyl phenoxyacetate (MPOA) as the acylating agents. The enzyme displays similar enantioselectivity with MPOA or MPA.
Tetrahedron Letters | 1998
David L. Varie; John Brennan; Barbara Shreve Briggs; Jason S. Cronin; David A. Hay; John Allan Rieck; Milton Joseph Zmijewski
Abstract Cryptophycin fragment A ( 1 ) was prepared in high enantiomeric purity in 10 steps from ( R )-carvone. A stereoselective bioreduction of ( R )-carvone to neodihydrocarveol and a regioselective Baeyer-Villiger oxidation of cyclohexanone 8 with pertrifluoroacetic acid were employed in this synthesis.
Biotechnology Letters | 1996
Thomas D. Black; Barbara Shreve Briggs; Robert S. Evans; William L. Muth; Surya Vangala; Milton Joseph Zmijewski
SummaryA dephthalylation step utilizing a novel enzyme, o-phthalyl amidase, was developed. This step was part of a potentially new large scale synthetic route for a novel beta-lactam antibiotic Loracarbef. The enzyme was isolated from the organism Xanthobacter agilis. Purification of the enzyme to near homogeneity was accomplished by a 3-step procedure. Studies indicated that the phthalimido group can be opened chemically to generate the o-phthalyl derivative. This enzyme then can remove the phthalyl group from o-phthalylated amides. Optimization of the process was achieved by combining these two hydrolysis steps. Conversion yields of 85–97.8% (mol/mol) were obtained from reactions at substrate concentrations of 5–10% (w/v).
Journal of Molecular Catalysis B-enzymatic | 1996
Barbara Shreve Briggs; Adam Joseph Kreuzman; Celia A. Whitesitt; Wu-Kuang Yeh; Milton Joseph Zmijewski
Abstract A selective screen for organisms that would metabolize o -phthalyl protected beta-lactams resulted in the discovery of a Xanthobacter agilis strain that contains an o -phthalyl amidase. The low level of enzyme expression in this organism could be enhanced by growing it on medium containing o -phthalate. The enzyme was purified to near homogeneity by a 6-step procedure. The phthalyl amidase was characterized for its molecular mass, amino acid composition, internal sequences, catalytic and kinetic properties. No metal ion was required by or stimulatory to the enzyme. The amidase catalyzed conversion could be complete with a reaction stoichiometry of 1:1. The pH and temperature stability of the enzyme is improved significantly by increasing ionic strength of the buffer. The enzyme exhibits a broad substrate specificity for o -phthalylated amides; however, it demonstrates an absolute requirement for the o -phthalyl protecting group. The broad substrate acceptance, high catalytic activity, and stability at high salt or substrate concentration of the enzyme indicates that it can serve as a gentle method for deprotecting phthalimido and o -phthalyl protected amides in new chemo-enzymatic synthetic routes.
Fems Microbiology Letters | 1989
Milton Joseph Zmijewski; Barbara Shreve Briggs
The Journal of Antibiotics | 1998
Nancy June Snyder; Robin D. G. Cooper; Barbara Shreve Briggs; Milton Joseph Zmijewski; Deborah L. Mullen; Raymond E. Kaiser; Thalia I. Nicas
Archive | 1995
Barbara Shreve Briggs; Milton Joseph Zmijewski
Journal of Natural Products | 1989
Milton Joseph Zmijewski; Robert M. Logan; Gary G. Marconi; Manuel Debono; R. Michael Molloy; Fred Chadwell; Barbara Shreve Briggs
Archive | 2002
James Abraham Aikins; Barbara Shreve Briggs; Tony Y. Zhang; Milton Joseph Zmijewski
Archive | 1995
Barbara Shreve Briggs; Milton Joseph Zmijewski